Jiudian Hongyang, which is wholly-owned subsidiary of Jiudian Pharmaceutical, obtained registration No. of Avobenzone (F20230000420) and Sucralose (F20230000345) from NMPA in Oct, 2023.

Sucralose has the characteristics of non-energy, high and pure sweetness, high safety, etc. It is the only functional sweetener made of sucrose, and its sweetness can be up to 600 times that of sucrose, but it doesn't damage the teeth and doesn't lead to diseases. Its safety has been proved to be extremely high in the long time toxicological test, and it is one of the most excellent functional sweeteners at present, and it is approved for use in more than 30 countries, including the United States, Canada, Australia, Russia and China, etc.

As a pharmaceutical excipient, Avobenzone is mainly used as a UV absorber in plasters to reduce the degradation of ketoprofen and other APIs under light conditions. It is classified as an over-the-counter (OTC) drug by FDA and is authorized for use in the U.S., and has been approved for use in the European Union and Japan, where it can be used as a safe and effective sunscreen. The registration publicity of Avobenzone represents that Hongyang has become the first enterprise to obtain the registration number of domestic medicinal Avobenzone.

Jiudian HongYang is committed to building an international high-end APIs and excipients manufacturer, and currently has 92 excipients varieties with registration numbers. In the future, it will continue to strengthen its technology and research and development strength in the wave of "domestic substitution", to promote the high-quality development of APIs and pharmaceutical excipients.